Bunch Paul M, Goyal Aakshit, Valenzuela Cristian D, Randle Reese W
Department of Radiology, Wake Forest School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157.
Department of Surgery, Wake Forest School of Medicine, Winston-Salem, NC.
AJR Am J Roentgenol. 2022 May;218(5):888-897. doi: 10.2214/AJR.21.26935. Epub 2021 Dec 22.
In patients with primary hyperparathyroidism (PHPT), bilateral neck exploration is necessary for multigland disease (MGD), whereas minimally invasive parathyroidectomy is often preferred for single-gland disease (SGD). An existing system (the 4D-CT MGD score) for differentiating SGD from MGD with the use of preoperative parathyroid CT considers the size of only the largest candidate lesion. The purpose of this study was to assess the utility of the size of the second-largest lesion on parathyroid CT for differentiating SGD from MGD as well as the utility of individual gland size for predicting the need for surgical removal and to derive optimal size thresholds for these purposes. This retrospective study included patients with PHPT who underwent biochemically successful parathyroidectomy after preoperative parathyroid CT. Clinical radiology reports were reviewed to classify reported candidate parathyroid lesions as low-, intermediate-, or high-confidence lesions. Resected hypercellular parathyroid lesions were correlated with clinically reported candidate lesions. Patients were classified as having SGD or MGD on the basis of operative and pathology reports, independent of CT findings. One observer retrospectively determined the estimated volume (0.52 × length × width × height) and maximum diameter of clinically reported high-confidence lesions, as well as the 4D-CT MGD scores from the examinations. Diagnostic performance was assessed. The sample comprised 62 patients (41 women, 21 men; median age, 65 years), 47 of whom had SGD and 15 of whom had MGD, with 151 candidate lesions, including 106 high-confidence lesions. Based on the second-largest high-confidence lesions, an estimated volume threshold of 60 mm or greater achieved 53% sensitivity and 96% specificity, whereas a maximum diameter threshold of 7 mm or greater achieved 67% sensitivity and 96% specificity for MGD; a 4D-CT MGD score of 3 or greater achieved 47% sensitivity and 68% specificity for MGD. For predicting the need to remove a gland for successful parathyroidectomy, an estimated volume threshold of 114 mm or greater achieved 84% sensitivity and 97% specificity, and a threshold of 55 mm or greater achieved 93% sensitivity and 87% specificity; a maximum diameter threshold of 7 mm or greater achieved 93% sensitivity and 84% specificity. The estimated volume and maximum diameter of high-confidence candidate lesions can differentiate SGD from MGD and identify individual glands requiring removal for successful parathyroidectomy. Differentiating SGD from MGD may be aided by considering both the first- and second-largest high-confidence lesions. The findings will help identify patients who are likely to require bilateral neck explorations, informing preoperative patient counseling and individualized operative planning.
在原发性甲状旁腺功能亢进症(PHPT)患者中,双侧颈部探查对于多腺体疾病(MGD)是必要的,而微创甲状旁腺切除术通常更适用于单腺体疾病(SGD)。现有的利用术前甲状旁腺CT区分SGD和MGD的系统(4D-CT MGD评分)仅考虑最大候选病变的大小。本研究的目的是评估甲状旁腺CT上第二大病变的大小在区分SGD和MGD方面的效用,以及单个腺体大小在预测手术切除必要性方面的效用,并得出用于这些目的的最佳大小阈值。这项回顾性研究纳入了术前进行甲状旁腺CT检查后接受生化指标成功改善的甲状旁腺切除术的PHPT患者。回顾临床放射学报告,将报告的候选甲状旁腺病变分类为低、中或高可信度病变。将切除的高细胞甲状旁腺病变与临床报告的候选病变进行关联。根据手术和病理报告将患者分类为患有SGD或MGD,与CT检查结果无关。一名观察者回顾性地确定临床报告的高可信度病变的估计体积(0.52×长×宽×高)和最大直径,以及检查的4D-CT MGD评分。评估诊断性能。样本包括62例患者(41名女性,21名男性;中位年龄65岁),其中47例患有SGD,15例患有MGD,有151个候选病变,包括106个高可信度病变。基于第二大高可信度病变,估计体积阈值≥60 mm时,MGD的敏感度为53%,特异度为96%;最大直径阈值≥7 mm时,MGD的敏感度为67%,特异度为96%;4D-CT MGD评分≥3时,MGD的敏感度为47%,特异度为68%。对于预测成功的甲状旁腺切除术中需要切除腺体的必要性,估计体积阈值≥114 mm时,敏感度为84%,特异度为97%;阈值≥55 mm时,敏感度为93%,特异度为87%;最大直径阈值≥7 mm时,敏感度为93%,特异度为84%。高可信度候选病变的估计体积和最大直径可以区分SGD和MGD,并识别成功的甲状旁腺切除术中需要切除的单个腺体。考虑第一和第二大高可信度病变可能有助于区分SGD和MGD。这些发现将有助于识别可能需要双侧颈部探查的患者,为术前患者咨询和个体化手术规划提供依据。